United States patent #10,738,095 granted on 2020-08-11
Australia patent #2016271292 granted 2022-07-28
Canada patent #2988086A1 granted 2023-05-02
European patent #3302527B1 granted 2020-01-08 (nationalized in 5 countries)
Japan patent #2017562777A granted 2020-11-18

WE ARE CURRENTLY PURSUING NEW METHOD OF USE IP.

XLock Biosciences has received a continuation of their patent US Patent 10738095, Engineered CCL20 locked dimer polypeptide, originally published August 11, 2020. Additional method of use patents are being reviewed by the USPTO.